<DOC>
	<DOC>NCT02367716</DOC>
	<brief_summary>The purpose of this clinical study is to observe the safety and efficacy of the multi-vector LV lead in Chinese patients that are indicated for Cardiac Resynchronization Therapy (CRT). This is a multi-center, non-randomized observational study. The total duration of the study is expected to be 2.5 years. The clinical study will be conducted in no more than 15 centers in China. Approximately 120 subjects will be enrolled in this study. Subjects will be followed up at 3, 6, 12months and every 6 months afterwards. All subjects need to be followed for at least 6 months.</brief_summary>
	<brief_title>Post-market Study of Multi-Vector LV Lead Performance in Chinese Patients With Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>• Meets the current ESC or ACCF/AHA/HRS Class I or Class IIa indications for CRT implant (including upgrades from single or dual chamber ICDs) Are ≥ 18 years of age at the time of enrolment. Are able to provide written Informed Consent prior to any study related procedure. • Patient who is unable to comply with the followup schedule. Patient who has any medical conditions that in the opinion of the investigator will not be appropriate to participate in the study . Patient has a life expectancy of less than 1 year due to any condition. Patients, who has a CRT device implanted</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>